St.Olavs University Hospital
Trondheim, 7006, Norway
NCT Number: NCT00964067
The purpose of the study is to compare home-based aerobic interval training with supervised interval training performed in groups or on a treadmill at the hospital.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Trondheim, 7006, Norway
Cardiac rehabilitation is usually first offered in hospitals, but there are several studies that show that home-based rehabilitation is equally efficient. How this comes out when exercise is organized as aerobic interval training is not known.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Interval training at 90% of max heart rate. Warm-up of 10-15 minutes up to 70% of HRmax, then 4 minutes of exercise at 90%. 3 minutes of active pause between the intervals. Total 45 minutes of exercise. Twice a week.
Time frame: baseline, after 12 weeks and after 1 year
Time frame: baseline, 12 weeks and 1 year
Norwegian University of Science and Technology
Other
Effect of High Intensity Aerobic Interval Training in Cardiac Rehabilitation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03419325
Acute Coronary Syndrome, Arterial Occlusive Diseases
Carolina, Puerto Rico
View Trial DetailsNCT05336435
Acute Coronary Syndrome, Angina Pectoris
Aabenraa, Denmark
View Trial DetailsNCT07519590
Arterial Occlusive Diseases, Arteriosclerosis
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT05966662
Arterial Occlusive Diseases, Arteriosclerosis
Huntsville, Alabama, United States
View Trial Details